Nanoparticle-based DNA vaccine protects against SARS-CoV-2 variants in female preclinical models.
Guimaraes LC, Costa PAC, Scalzo Júnior SRA, Ferreira HAS, Braga ACS, de Oliveira LC, Figueiredo MM, Shepherd S, Hamilton A, Queiroz-Junior CM, da Silva WN, da Silva NJA, Rodrigues Alves MT, Santos AK, de Faria KKS, Marim FM, Fukumasu H, Birbrair A, Teixeira-Carvalho A, de Aguiar RS, Mitchell MJ, Teixeira MM, Vasconcelos Costa V, Frezard F, Guimaraes PPG.
Guimaraes LC, et al.
Nat Commun. 2024 Jan 18;15(1):590. doi: 10.1038/s41467-024-44830-1.
Nat Commun. 2024.
PMID: 38238326
Free PMC article.